Literature DB >> 197102

Liposome oxidation and erythrocyte lysis by enzymically generated superoxide and hydrogen peroxide.

E W Kellogg, I Fridovich.   

Abstract

Xanthine oxidase, acting on acetaldehyde under aerobic conditions, produces a flux of O2- and H2O2 which attacks artificial liposomes and washed human erythrocytes. The liposomes were peroxidized and the erythrocytes suffered oxidation of hemoglobin followed by lysis. The oxidation of hemoglobin followed by lysis. The oxidation of hemoglobin, within the exposed erythrocytes, could be largely prevented by prior conversion to carbon monoxyhemoglobin, without preventing lysis. Hemolysis thus appeared to be a consequence of direct oxidative attack on the cell stroma. The enzyme-generated flux of O2- and of H2O2 also inactivated the xanthine oxidase. Superoxide dismutase or catalase, present in the suspending medium, protected the liposomes against peroxidation, the erythrocytes against lysis, and the xanthine oxidase against inactivation. Scavengers of O2('deltag), such as histidine or 2,5-dimethylfuran, which do not react with O2- or H2O2, also prevented peroxidation of liposomes and lysis of erythrocytes when present at low concentrations. In contrast a scavenger of OH-, such as mannitol was ineffective at low concentrations and provided significant protection only at much higher concentrations. It is proposed that O2- and H2O2 cooperated in producing OH- and O2('deltag), which were the proximate causes of lipid peroxidation and of hemolysis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 197102

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Evidence for the involvement of superoxide in vitamin K-dependent carboxylation of glutamic acid residues of prothrombin.

Authors:  M P Esnouf; M R Green; H A Hill; G B Irvine; S J Walter
Journal:  Biochem J       Date:  1978-07-15       Impact factor: 3.857

Review 2.  Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.

Authors:  T A Merritt; M Hallman; R Spragg; G P Heldt; N Gilliard
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

3.  Developmental regulation of rat lung Cu,Zn-superoxide dismutase.

Authors:  M A Hass; D Massaro
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

Review 4.  Mechanisms of oxidant-induced changes in erythrocytes.

Authors:  J R Hatherill; G O Till; P A Ward
Journal:  Agents Actions       Date:  1991-03

5.  Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors.

Authors:  Lenka Hasikova; Marketa Pavlikova; Hana Hulejova; Petr Kozlik; Kveta Kalikova; Aparna Mahajan; Martin Herrmann; Blanka Stiburkova; Jakub Zavada
Journal:  Rheumatol Int       Date:  2019-07-31       Impact factor: 2.631

Review 6.  Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.

Authors:  J G Williams
Journal:  Ann R Coll Surg Engl       Date:  1990-07       Impact factor: 1.891

7.  Cell multiplication of an ascites tumour in the presence of superoxide dismutase and catalase.

Authors:  F S Liotti; P Guerrieri; A R Menghini; F Pezzetti
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

8.  Serum lipid peroxide level and blood superoxide dismutase activity in workers with occupational exposure to lead.

Authors:  Y Ito; Y Niiya; H Kurita; S Shima; S Sarai
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

9.  Effects of D-penicillamine on a model of oxygen-derived free radical mediated tissue damage.

Authors:  W H Betts; L G Cleland; D J Gee; M W Whitehouse
Journal:  Agents Actions       Date:  1984-02

10.  Higher serum uric acid is associated with higher lumbar spine bone mineral density in male health-screening examinees: a cross-sectional study.

Authors:  Jiwon Hwang; Jung Hye Hwang; Seungho Ryu; Joong Kyong Ahn
Journal:  J Bone Miner Metab       Date:  2018-01-25       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.